Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133643670> ?p ?o ?g. }
- W3133643670 endingPage "3285" @default.
- W3133643670 startingPage "3277" @default.
- W3133643670 abstract "In this phase I study, we evaluated the safety, biodistribution and dosimetry of [89Zr]Zr-DFO-girentuximab (89Zr-girentuximab) PET/CT imaging in patients with suspicion of clear cell renal cell carcinoma (ccRCC).Ten eligible patients received an intravenous administration of 37 MBq (± 10%) of 89Zr-girentuximab at mass doses of 5 mg or 10 mg. Safety was evaluated according to the NCI CTCAE (version 4.03). Biodistribution and normal organ dosimetry was performed based on PET/CT images acquired at 0.5, 4, 24, 72 and 168 h post-administration. Additionally, tumour dosimetry was performed in patients with confirmed ccRCC and visible tumour uptake on PET/CT imaging.89Zr-girentuximab was administered in ten patients as per protocol. No treatment-related adverse events ≥ grade 3 were reported. 89Zr-girentuximab imaging allowed successful differentiation between ccRCC and non-ccRCC lesions in all patients, as confirmed with histological data. Dosimetry analysis using OLINDA/EXM 2.1 showed that the organs receiving the highest doses (mean ± SD) were the liver (1.86 ± 0.40 mGy/MBq), the kidneys (1.50 ± 0.22 mGy/MBq) and the heart wall (1.45 ± 0.19 mGy/MBq), with a mean whole body effective dose of 0.57 ± 0.08 mSv/MBq. Tumour dosimetry was performed in the 6 patients with histologically confirmed ccRCC resulting in a median tumour-absorbed dose of 4.03 mGy/MBq (range 1.90-11.6 mGy/MBq).This study demonstrates that 89Zr-girentuximab is safe and well tolerated for the administered activities and mass doses and allows quantitative assessment of 89Zr-girentuximab PET/CT imaging in patients with suspicion of ccRCC.NCT03556046-14th of June, 2018." @default.
- W3133643670 created "2021-03-15" @default.
- W3133643670 creator A5017251514 @default.
- W3133643670 creator A5034316562 @default.
- W3133643670 creator A5050200817 @default.
- W3133643670 creator A5056620057 @default.
- W3133643670 creator A5062519984 @default.
- W3133643670 creator A5065299486 @default.
- W3133643670 creator A5074036165 @default.
- W3133643670 creator A5081904946 @default.
- W3133643670 date "2021-03-02" @default.
- W3133643670 modified "2023-10-16" @default.
- W3133643670 title "Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma" @default.
- W3133643670 cites W1974678574 @default.
- W3133643670 cites W1987729908 @default.
- W3133643670 cites W1987825597 @default.
- W3133643670 cites W1996400431 @default.
- W3133643670 cites W2013197178 @default.
- W3133643670 cites W2057600943 @default.
- W3133643670 cites W2068555261 @default.
- W3133643670 cites W2082071176 @default.
- W3133643670 cites W2100256417 @default.
- W3133643670 cites W2100718450 @default.
- W3133643670 cites W2128219736 @default.
- W3133643670 cites W2141371088 @default.
- W3133643670 cites W2142384833 @default.
- W3133643670 cites W2143804648 @default.
- W3133643670 cites W2148483304 @default.
- W3133643670 cites W2154289925 @default.
- W3133643670 cites W2161621282 @default.
- W3133643670 cites W2162719553 @default.
- W3133643670 cites W2168966763 @default.
- W3133643670 cites W2198388156 @default.
- W3133643670 cites W2275409062 @default.
- W3133643670 cites W2345989459 @default.
- W3133643670 cites W2423795493 @default.
- W3133643670 cites W2530608546 @default.
- W3133643670 cites W2652858501 @default.
- W3133643670 cites W2769853159 @default.
- W3133643670 cites W2791002029 @default.
- W3133643670 cites W2801006828 @default.
- W3133643670 cites W2892325025 @default.
- W3133643670 cites W2897061121 @default.
- W3133643670 cites W2898673472 @default.
- W3133643670 cites W2948579877 @default.
- W3133643670 doi "https://doi.org/10.1007/s00259-021-05271-w" @default.
- W3133643670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8426244" @default.
- W3133643670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33651116" @default.
- W3133643670 hasPublicationYear "2021" @default.
- W3133643670 type Work @default.
- W3133643670 sameAs 3133643670 @default.
- W3133643670 citedByCount "20" @default.
- W3133643670 countsByYear W31336436702021 @default.
- W3133643670 countsByYear W31336436702022 @default.
- W3133643670 countsByYear W31336436702023 @default.
- W3133643670 crossrefType "journal-article" @default.
- W3133643670 hasAuthorship W3133643670A5017251514 @default.
- W3133643670 hasAuthorship W3133643670A5034316562 @default.
- W3133643670 hasAuthorship W3133643670A5050200817 @default.
- W3133643670 hasAuthorship W3133643670A5056620057 @default.
- W3133643670 hasAuthorship W3133643670A5062519984 @default.
- W3133643670 hasAuthorship W3133643670A5065299486 @default.
- W3133643670 hasAuthorship W3133643670A5074036165 @default.
- W3133643670 hasAuthorship W3133643670A5081904946 @default.
- W3133643670 hasBestOaLocation W31336436701 @default.
- W3133643670 hasConcept C126838900 @default.
- W3133643670 hasConcept C142724271 @default.
- W3133643670 hasConcept C149857219 @default.
- W3133643670 hasConcept C150903083 @default.
- W3133643670 hasConcept C207001950 @default.
- W3133643670 hasConcept C2777472916 @default.
- W3133643670 hasConcept C2777807558 @default.
- W3133643670 hasConcept C2989005 @default.
- W3133643670 hasConcept C71924100 @default.
- W3133643670 hasConcept C75088862 @default.
- W3133643670 hasConcept C86803240 @default.
- W3133643670 hasConceptScore W3133643670C126838900 @default.
- W3133643670 hasConceptScore W3133643670C142724271 @default.
- W3133643670 hasConceptScore W3133643670C149857219 @default.
- W3133643670 hasConceptScore W3133643670C150903083 @default.
- W3133643670 hasConceptScore W3133643670C207001950 @default.
- W3133643670 hasConceptScore W3133643670C2777472916 @default.
- W3133643670 hasConceptScore W3133643670C2777807558 @default.
- W3133643670 hasConceptScore W3133643670C2989005 @default.
- W3133643670 hasConceptScore W3133643670C71924100 @default.
- W3133643670 hasConceptScore W3133643670C75088862 @default.
- W3133643670 hasConceptScore W3133643670C86803240 @default.
- W3133643670 hasIssue "10" @default.
- W3133643670 hasLocation W31336436701 @default.
- W3133643670 hasLocation W31336436702 @default.
- W3133643670 hasLocation W31336436703 @default.
- W3133643670 hasLocation W31336436704 @default.
- W3133643670 hasOpenAccess W3133643670 @default.
- W3133643670 hasPrimaryLocation W31336436701 @default.
- W3133643670 hasRelatedWork W1987262526 @default.
- W3133643670 hasRelatedWork W2043240363 @default.
- W3133643670 hasRelatedWork W2074647699 @default.
- W3133643670 hasRelatedWork W2090813581 @default.